☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
Groups
AstraZeneca Expands the Development of AZD1222 into P-III Study in the US Across All Adult Age Groups
September 1, 2020
Load more...
Back to Home